Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1986 Sep;78(3):622–628. doi: 10.1172/JCI112619

Chronic 1,25-dihydroxyvitamin D3 administration in the rat reduces the serum concentration of 25-hydroxyvitamin D by increasing metabolic clearance rate.

B P Halloran, D D Bikle, M J Levens, M E Castro, R K Globus, E Holton
PMCID: PMC423635  PMID: 3489007

Abstract

Administration of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] can lower the serum concentration of 25-hydroxyvitamin (25-OH-D). To determine if 1,25(OH)2D3 lowers serum 25-OH-D by increasing clearance or reducing production, we directly measured the metabolic clearance rate (MCR) of 25-OH-D in rats chronically infused with 1,25(OH)2D3. Chronic 1,25(OH)2D3 administration (0 to 75 pmol/d) reduced, in a time- and dose-dependent fashion, the serum concentrations of 25-OH-D3 and 24,25(OH)2D3 from 18 +/- 2 to 9 +/- 1 ng/ml and from 4.8 +/- 0.7 to 1.3 +/- 0.3 ng/ml, respectively, and increased sevenfold the in vitro conversion of 25-OH-D to 24,25(OH)2D3 by kidney homogenates. The reduction in serum 25-OH-D3 was completely accounted for by an increase in MCR. No change in production occurred. The influence of 1,25(OH)2D3 on serum 25-OH-D3 and 24,25(OH)2D3 was shown not to be dependent on induction of hypercalcemia. These data suggest that chronic 1,25(OH)2D3 administration lowers serum 25-OH-D by increasing the metabolic clearance of 25-OH-D3 and not by decreasing its production.

Full text

PDF
624

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baran D. T., Milne M. L. 1,25 dihydroxyvitamin D-induced inhibition of 3H-25 hydroxyvitamin D production by the rachitic rat liver in vitro. Calcif Tissue Int. 1983 Jul;35(4-5):461–464. doi: 10.1007/BF02405077. [DOI] [PubMed] [Google Scholar]
  2. Bell N. H., Shaw S., Turner R. T. Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. J Clin Invest. 1984 Oct;74(4):1540–1544. doi: 10.1172/JCI111568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bikle D. D. Studies of the chick renal mitochondrial 25-hydroxyvitamin D-3 24-hydroxylase. Biochim Biophys Acta. 1980 Sep 9;615(1):208–222. doi: 10.1016/0005-2744(80)90024-8. [DOI] [PubMed] [Google Scholar]
  4. Colston K., Feldman D. 1,25-Dihydroxyvitamin D3 receptors and functions in cultured pig kidney cells (LLC PK1). Regulation of 24,25-dihydroxyvitamin D3 production. J Biol Chem. 1982 Mar 10;257(5):2504–2508. [PubMed] [Google Scholar]
  5. DeLuca H. F., Schnoes H. K. Vitamin D: recent advances. Annu Rev Biochem. 1983;52:411–439. doi: 10.1146/annurev.bi.52.070183.002211. [DOI] [PubMed] [Google Scholar]
  6. Fraser D. R. Regulation of the metabolism of vitamin D. Physiol Rev. 1980 Apr;60(2):551–613. doi: 10.1152/physrev.1980.60.2.551. [DOI] [PubMed] [Google Scholar]
  7. Haddad J. G., Stamp T. C. Circulating 25-hydroxyvitamin D in man. Am J Med. 1974 Jul;57(1):57–62. doi: 10.1016/0002-9343(74)90768-2. [DOI] [PubMed] [Google Scholar]
  8. Halloran B. P., Schaefer P., Lifschitz M., Levens M., Goldsmith R. S. Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3. J Clin Endocrinol Metab. 1984 Dec;59(6):1063–1069. doi: 10.1210/jcem-59-6-1063. [DOI] [PubMed] [Google Scholar]
  9. Henry H. L. Regulation of the hydroxylation of 25-hydroxyvitamin D3 in vivo and in primary cultures of chick kidney cells. J Biol Chem. 1979 Apr 25;254(8):2722–2729. [PubMed] [Google Scholar]
  10. Horst R. L., Littledike E. T., Gray R. W., Napoli J. L. Impaired 24,25-dihydroxyvitamin D production in anephric human and pig. J Clin Invest. 1981 Jan;67(1):274–280. doi: 10.1172/JCI110023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Howard G. A., Turner R. T., Bottemiller B. L., Rader J. I. Serum-free culture of Japanese quail kidney cells. Regulation of vitamin D metabolism. Biochim Biophys Acta. 1979 Nov 1;587(4):495–506. doi: 10.1016/0304-4165(79)90003-5. [DOI] [PubMed] [Google Scholar]
  12. Hughes M. R., Baylink D. J., Jones P. G., Haussler M. R. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3. J Clin Invest. 1976 Jul;58(1):61–70. doi: 10.1172/JCI108459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Juan D., DeLUCA H. F. The regulation of 24,25-dihydroxyvitamin D3 production in cultures of monkey kidney cells. Endocrinology. 1977 Oct;101(4):1184–1193. doi: 10.1210/endo-101-4-1184. [DOI] [PubMed] [Google Scholar]
  14. LeBel D., Poirier G. G., Beaudoin A. R. A convenient method for the ATPase assay. Anal Biochem. 1978 Mar;85(1):86–89. doi: 10.1016/0003-2697(78)90277-4. [DOI] [PubMed] [Google Scholar]
  15. Loré F., Di Cairano G., Periti P., Caniggia A. Effect of the administration of 1,25-dihydroxyvitamin D3 on serum levels of 25-hydroxyvitamin D in postmenopausal osteoporosis. Calcif Tissue Int. 1982;34(6):539–541. doi: 10.1007/BF02411300. [DOI] [PubMed] [Google Scholar]
  16. Mawer E. B., Reeve A. The use of an isolated perfused liver to study the control of cholecalciferol-25-hydroxylase activity in the rat. Calcif Tissue Res. 1977 May;22 (Suppl):24–28. doi: 10.1007/BF02064035. [DOI] [PubMed] [Google Scholar]
  17. Milne M. L., Baran D. T. End product inhibition of hepatic 25-hydroxyvitamin D production in the rat: specificity and kinetics. Arch Biochem Biophys. 1985 Nov 1;242(2):488–492. doi: 10.1016/0003-9861(85)90234-6. [DOI] [PubMed] [Google Scholar]
  18. Prince M. J., Schaeffer P. C., Goldsmith R. S., Chausmer A. B. Hyperphosphatemic tumoral calcinosis: association with elevation of serum 1,25-dihydroxycholecalciferol concentrations. Ann Intern Med. 1982 May;96(5):586–591. doi: 10.7326/0003-4819-96-5-586. [DOI] [PubMed] [Google Scholar]
  19. Reinhardt T. A., Horst R. L., Orf J. W., Hollis B. W. A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab. 1984 Jan;58(1):91–98. doi: 10.1210/jcem-58-1-91. [DOI] [PubMed] [Google Scholar]
  20. Shepard R. M., Horst R. L., Hamstra A. J., DeLuca H. F. Determination of vitamin D and its metabolites in plasma from normal and anephric man. Biochem J. 1979 Jul 15;182(1):55–69. doi: 10.1042/bj1820055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Spanos E., Barrett D. I., Chong K. T., MacIntyre I. Effect of oestrogen and 1,25-dihydroxycholecalciferol on 25-hydroxycholecalciferol metabolism in primary chick kidney-cell cultures. Biochem J. 1978 Jul 15;174(1):231–236. doi: 10.1042/bj1740231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Stern P. H., De Olazabal J., Bell N. H. Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism. J Clin Invest. 1980 Oct;66(4):852–855. doi: 10.1172/JCI109924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Suda T., DeLuca H. F., Tanaka Y. Biological activity of 25-hydroxyergocalciferol in rats. J Nutr. 1970 Sep;100(9):1049–1052. doi: 10.1093/jn/100.9.1049. [DOI] [PubMed] [Google Scholar]
  24. TAIT J. F., LITTLE B., TAIT S. A., FLOOD C. The metabolic clearance rate of aldosterone in pregnant and nonpregnant subjects estimated by both single-injection and constant-infusion methods. J Clin Invest. 1962 Dec;41:2093–2100. doi: 10.1172/JCI104667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. TAIT J. F. REVIEW: THE USE OF ISOTOPIC STEROIDS FOR THE MEASUREMENT OF PRODUCTION RATES IN VIVO. J Clin Endocrinol Metab. 1963 Dec;23:1285–1297. doi: 10.1210/jcem-23-12-1285. [DOI] [PubMed] [Google Scholar]
  26. Trechsel U., Bonjour J. P., Fleisch H. Regulation of the metabolism of 25-hydroxyvitamin D3 in primary cultures of chick kidney cells. J Clin Invest. 1979 Jul;64(1):206–217. doi: 10.1172/JCI109441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Zerwekh J. E., Glass K., Jowsey J., Pak C. Y. An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D. J Clin Endocrinol Metab. 1979 Aug;49(2):171–175. doi: 10.1210/jcem-49-2-171. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES